Strategy
Stages
SeedSeries ASeries B
Sectors
HealthcareEnterpriseFintech
Geographies
USAStamford, Connecticut, USA
Check size
$1M-$50MRecent changes
- Sep 9, 2026Sep 9, 2026Invested in Solstice Oncology (Series A, $225M) GlobeNewswire
Portfolio
1 totalRecent Investment Activity
1Track record: led 0 and participated in 1 of 1 tracked venture round · 1 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Solstice Oncology | Series A | Participated | $225M | — | GlobeNewswire |
Co-Investors
2Similar Firms
overlapping sector, stage or regionLatest Pulse
- Sep 9, 2026Solstice Oncology Launches With $225M Series ASolstice Oncology launched with a $225 million Series A led by RA Capital Management to advance porustobart, a second-generation CTLA-4 immunotherapy licensed from Harbour BioMed, into two Phase 2 cancer trials.→
- Jul 29, 2026Mate Security Tops $50M as AI Security Ops Heads to Black HatMate Security, founded by former SentinelOne and Wiz leaders, closed a $35 million Series A led by Canaan Partners, pushing its total funding past $50 million as it heads to Black Hat USA.→
Canaan Partners FAQ
What companies has Canaan Partners invested in?
Canaan Partners' portfolio includes Solstice Oncology.
Who does Canaan Partners co-invest with most?
In the rounds Value Add tracks, Canaan Partners most often invests alongside Forbion Capital Partners (1 shared deal), RA Capital (1 shared deal).
Sources & methodologyshow
Where these figures come from
- GlobeNewswireprimary source1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.